Emphysema pathophysiology
Pro Research Analysisby 
Searched over 200M research papers for "emphysema pathophysiology"
Decreased Pulmonary Elastic Recoil and Airflow Limitation in Emphysema Pathophysiology
Emphysema is primarily characterized by a loss of pulmonary elastic recoil, which means the lungs do not return to their normal shape after inhaling. This leads to higher lung volumes at any given pleural pressure and makes the airways more prone to collapse, especially during forced expiration. As a result, airflow is limited, and in severe cases, this limitation can even occur during normal breathing. The destruction of alveolar walls and changes in the relationship between pleural and alveolar pressures further contribute to this dynamic airway compression and airflow obstruction. Additionally, both large and small airway diseases play a role in limiting airflow in emphysema patients 123.
Protease-Antiprotease Imbalance and Lung Parenchymal Destruction
A key mechanism in emphysema development is the imbalance between proteases and antiproteases, often triggered by cigarette smoke exposure. This imbalance leads to the destruction of lung parenchyma, particularly the elastic fibers and collagen that provide structural support. The resulting tissue damage causes air trapping, increased lung compliance, and hyperinflation, which complicate inspiration and contribute to the sensation of breathlessness (dyspnea) 39.
Oxidative Stress and Impaired Antioxidant Response
Oxidative stress is another important factor in emphysema pathophysiology. In emphysema, there is an increased oxidative burden and a decreased level of antioxidant proteins. This is partly due to altered regulation of key transcription factors such as Nrf2, Keap1, and Bach1, which control the expression of antioxidant enzymes. In emphysema, Nrf2 levels are reduced, while Keap1 and Bach1 are increased, leading to lower expression of protective antioxidant proteins and a diminished cellular stress response. This imbalance is closely linked to airway obstruction and lung tissue damage 510.
Inflammation, Senescence, and Gene Expression Changes
Chronic inflammation and cellular aging (senescence) are also central to emphysema. Experimental models show that emphysema is associated with stable increases in inflammatory and senescence-related markers. MicroRNAs, such as miR-638, are altered in emphysematous lung tissue and regulate gene networks involved in oxidative stress and aging, further contributing to lung destruction 710.
Mucus Plugs, Airway Disease, and Clinical Outcomes
In addition to parenchymal destruction, mucus plugs and airway disease independently contribute to airflow limitation and hypoxemia in smokers with emphysema. Mucus plugs are common, often present without symptoms, and are associated with worse lung function, more frequent exacerbations, and reduced exercise capacity. These findings highlight the importance of both airway and parenchymal changes in the clinical presentation of emphysema .
Matrix Metalloproteinases and Extracellular Matrix Degradation
Matrix metalloproteinases (MMPs) are enzymes that degrade extracellular matrix proteins such as elastin and collagen. In emphysema, increased MMP activity leads to the destruction of these structural proteins, further weakening the lung tissue and promoting the development of emphysematous changes .
Conclusion
Emphysema pathophysiology is driven by a combination of decreased elastic recoil, protease-antiprotease imbalance, oxidative stress, chronic inflammation, and airway disease. These processes lead to airflow limitation, lung hyperinflation, and progressive destruction of lung tissue, resulting in the characteristic symptoms and clinical outcomes of the disease 1235+4 MORE.
Sources and full results
Most relevant research papers on this topic